WorldPoultry: Hendrix Genetics (ISA) expects turnover to double

LAYERS
Hendrix Genetics, one of the world’s largest animal breeding companies, expects to see its turnover almost double to €600 million within the next five years.

Hendrix Genetics, headquartered in the Netherlands, is the holding company of various breeding business units, like Hypor (pigs), ISA (layers), Hybrid (turkeys), Caringa (traditional poultry) and Landcatch (aqua). The company hopes to grow further having a new shareholder, i.e. NPM Capital.

Ready for further consolidation

In an interview with the Dutch financial newspaper Financieele Dagblad, Thijs Hendrix, president, Hendrix Genetics was quoted to say, "We are ready for further consolidating the industry."

The company has already grown dramatically during the last decade, having started out with 50 employees and being at 2,500 at the moment. This growth was partly achieved by takeovers. This month, NPM Capital, part of SHV Holdings, acquired almost 25% of the company's shares. The remainder is owned by the Hendrix family (56%), a French investor and Antoon van den Berg, the company's CEO.

World population continues to grow

The opportunities for the company are in the international field, Hendrix says. World population continues to grow, so the demand for poultry, eggs, pigs and aquaculture will continue to grow as well. In the short term, the company envisages growth opportunities in Russia, which aims to achieve self-sufficiency in agriculture. Hendrix also mentioned the Americas and Asia.\

In this light, the turnover is expected to grow from €390 million this year to €600 million in 2020. The board of directors expects this to happen both by autonomous growth as well as by further takeovers, with major contributions from France, the US and Canada.

Net profit is expected to even treble to a level of approximately €45 million.

15% in research

Hendrix Genetics produces animals and eggs for breeding purposes as well as software for breeding programmes. Annually, the company invests about 15% of revenue into R&D. The research of about 200 specialists is invested in all five business units.
by VINCENT TER BEEK Jul 27, 2015